ABSTRACT
It was revealed that beta-endorphin modulation of lymphocyte proliferative activity in male donors was predominantly observed under younger age groups of 20-29 and 30-39 years, while with age it gradually decreased and disappeared as such in group of donors under 50-60 years. Meanwhile, females demonstrated prolonged modulating effect of peptide on the proliferation. In female group under 50-59 years the peptide was found to render marked promoting effect on the spontaneous proliferation in concentrations of 10(-7), 10(-8), and 10(-10) M that was induced by suboptimal PHA concentration of 10(-10) M, whereas women in the range of 30-39 years showed that beta-endorphin suppressed the PHA-induced proliferative response. Male donors in age group of 20-29 years demonstrated beta-endorphin-stimulated and in age group of 50-59 years beta-endorphin-suppressed uptake capacity of neutrophils. In female donors from all age groups the effect of beta-endorphin on neutrophil phagocyte activity was not observed.
Subject(s)
Aging/physiology , Cell Proliferation/drug effects , Lymphocytes/metabolism , Neutrophils/metabolism , Phagocytosis/drug effects , Sex Characteristics , beta-Endorphin/pharmacology , Adult , Dose-Response Relationship, Drug , Female , Humans , Lymphocytes/cytology , Male , Middle Aged , Mitogens/pharmacology , Neutrophils/cytology , Phagocytosis/physiology , Phytohemagglutinins/pharmacologyABSTRACT
The paper deals with the diagnosis of optic nerve atrophy caused by temporal giant-cell arteritis (Horton's disease) and shows how difficult to make a differential diagnosis between glaucoma and other non-eye diseases that also induce optic nerve atrophy. It describes a clinical case that illustrates the difficulties in diagnosing optic nerve involvement in Horton's disease.